Form 4: LivaNova Executive Franco Poletti Reports Share Transactions Following RSU Vesting

LivaNova's President of Cardiopulmonary, Franco Poletti, reports the vesting of restricted stock units and subsequent share transactions.

Summary

• Franco Poletti, President of Cardiopulmonary at LivaNova PLC, reported transactions involving the company's ordinary shares on December 15, 2024.
• These transactions include the vesting of 967 restricted stock units (RSUs), which converted into 967 ordinary shares.
• Additionally, 416 shares were withheld to cover tax liabilities related to the vesting.
• Following these transactions, Mr. Poletti directly owns 7,218 ordinary shares and indirectly owns 219 shares through his spouse.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction related to executive compensation. It is neither particularly positive nor negative, but indicates that the executive is receiving compensation as expected.

Positives

• The vesting of RSUs indicates that performance milestones were likely met, which is a positive sign for the company.
• The executive's continued ownership of shares aligns his interests with those of shareholders.

Risks

• The sale of shares to cover tax liabilities could be perceived negatively by some investors, although it is a common practice.

Industry Context

This is a standard SEC Form 4 filing, which is common for executives of publicly traded companies when they have transactions involving company stock. It is a routine disclosure and does not indicate any specific trend in the medical device industry.

Comparison to Industry Standards

• Executive compensation packages often include restricted stock units that vest over time, similar to the arrangement for Mr. Poletti.
• Tax withholding on vesting shares is a standard practice across publicly traded companies, including those in the medical device sector such as Medtronic and Abbott.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect the standard vesting of executive compensation.

Key Dates

Keywords

LivaNova, Franco Poletti, Restricted Stock Units, RSU, Share Transactions, Beneficial Ownership, Cardiopulmonary, Vesting